Chemed Corp (CHE): Price and Financial Metrics


Chemed Corp (CHE)

Today's Latest Price: $529.20 USD

7.20 (1.38%)

Updated Jan 15 7:00pm

Add CHE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

CHE Stock Summary

  • CHE's went public 35.06 years ago, making it older than 92.8% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of -46.07%, Chemed Corp's debt growth rate surpasses only 6.81% of about US stocks.
  • In terms of volatility of its share price, CHE is more volatile than just 4.82% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Chemed Corp, a group of peers worth examining would be PWR, ICLR, JOBS, MMS, and HLI.
  • CHE's SEC filings can be seen here. And to visit Chemed Corp's official web site, go to www.chemed.com.

CHE Stock Price Chart Interactive Chart >

Price chart for CHE

CHE Price/Volume Stats

Current price $529.20 52-week high $553.38
Prev. close $522.00 52-week low $330.01
Day low $518.98 Volume 118,500
Day high $532.02 Avg. volume 99,960
50-day MA $503.65 Dividend yield 0.26%
200-day MA $479.60 Market Cap 8.44B

Chemed Corp (CHE) Company Bio


Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is based in Cincinnati, Ohio.

CHE Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$529.20$682.68 29%

Below please find a table outlining a discounted cash flow forecast for CHE, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Chemed Corp ranked in the 58th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 29.67% on a DCF basis. The most interesting components of our discounted cash flow analysis for Chemed Corp ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 106.08 -- which is good for besting 95.79% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than just 8.22% of the free cash flow producing stocks we're observing.
  • CHE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 50.57% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%26%
1%28%
2%29%
3%30%
4%32%
5%33%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CHE, try HBIO, JAZZ, PBH, UTHR, and PRAH.


CHE Latest News Stream


Event/Time News Detail
Loading, please wait...

CHE Latest Social Stream


Loading social stream, please wait...

View Full CHE Social Stream

Latest CHE News From Around the Web

Below are the latest news stories about Chemed Corp that investors may wish to consider to help them evaluate CHE as an investment opportunity.

'Halftime Report' Final Trades: CVS Health, Bilibili And More

On CNBC's "Fast Money Halftime Report," the investment committee gave their final trades. Decatur Capital Management CEO Degas Wright likes Chemed Corporation (NYSE: CHE ). Sand Hill Global Advisors Brenda Vingiello likes CVS Health Corporation (NYSE: … Full story available on Benzinga.com

Benzinga | January 8, 2021

Is Chemed Corporation's (NYSE:CHE) Latest Stock Performance A Reflection Of Its Financial Health?

Chemed (NYSE:CHE) has had a great run on the share market with its stock up by a significant 15% over the last month...

Yahoo | January 7, 2021

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA vs. CHE: Which Stock Is the Better Value Option?

Yahoo | December 29, 2020

Align (ALGN) Rides on Robust Invisalign Sales Amid Coronavirus

Align Technology's (ALGN) Invisalign clear aligner has been receiving positive feedback and holds huge long-term market potential.

Yahoo | December 29, 2020

CVS Health's (CVS) Front Store Sales Robust, LTC Suffers

CVS Health's (CVS) Health Care Benefits arm benefits from strong Medicare annual enrollment period.

Yahoo | December 29, 2020

Read More 'CHE' Stories Here

CHE Price Returns

1-mo -1.77%
3-mo 8.81%
6-mo 11.88%
1-year 11.99%
3-year 100.60%
5-year 280.59%
YTD -0.64%
2020 21.59%
2019 55.58%
2018 17.01%
2017 52.32%
2016 7.89%

CHE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CHE Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8315 seconds.